Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors
Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The investigators plan to improve event free survival rate and reduce treatment related
toxicities of pediatric patients with high risk/recurrent CNS tumors by administrating tandem
high dose chemotherapy and autologous stem cell rescue.